Safety and Pharmacokinetics (PK) of AMG 706 With Carboplatin/Paclitaxel (C/P) and/or Panitumumab for the treatment of patients with advanced non-small cell lung cancer (NSCLC)

被引：8

作者：

Blumenschein, George R., Jr.

Sandler, Alan

O'Rourke, Timothy

McGreivy, Jesse

Sun, Yu-Nien

Ye, Yining

Parson, Mandy

Stephenson, Joe J.

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Vanderbilt Univ, Nashville, TN USA

[3] Spectrum Hlth, Grand Rapids, MI USA

[4] Amgen Inc, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, San Francisco, CA USA

[6] Canc Ctr Carolinas, Greenville, SC USA

来源：

关键词：

D O I：

10.1097/01.JTO.0000283417.64982.90

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S469 / S469

页数：1